Podstawy i tryb wprowadzania do obrotu środków odurzających, substancji psychotropowych i nowych substancji psychoaktywnych
Basics and Procedure for Introducing Narcotic Drugs, Psychotropic Substances, and New Psychoactive Substances into Circulation

Summary/Abstract: This article examines the legal basis and procedure for introducing narcotic drugs, psychotropic substances, and new psychoactive substances into the market. To this end, the provisions of the Act of 29 July 2005 on Counteracting Drug Addiction, as amended in 2018 to address the issue of unlimited access to so-called “legal highs”, are discussed. The introduction of narcotic drugs and psychotropic substances to the market requires obtaining a permit from the Chief Pharmaceutical Inspector, while new psychoactive substances require approval from the President of the Bureau for Chemical Substances. In this way, the legislator has limited the freedom of economic activity to protect human life and health. The establishment of a catalog of substances subject to legal regulation through a regulation, a sub-statutory legal act, is also significant. This allows for the rapid restriction of access to substances considered dangerous.

• Details
• Contents